ZZH-24907-37574
6 vaccinations
2 coded responses
59 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 480 / MI
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Pfizer-BioNTech
- 2021-03-04
-
2021-03-05
Survey response — days 1–6 daily, dose 1MedDRA: Headache — Feeling: Good · Site: Pain · HeadacheFree text: The headache reported above was actually yesterday (3/4/2021) after my first daily v-safe check-in. It was of moderate severity and resolved on its own (no meds) a few hours after onset. No headache today (3/5/2021).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
-
2021-03-25
Dose 2 — Pfizer-BioNTech
- 2021-03-25
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-08
- 2021-04-15
-
2021-04-22
Survey response — day 28, dose 2MedDRA: Injection site erythema, Injection site pruritus — Feeling: GoodFree text: Slightly reddish round patch (not raised), ca. 30mm in diameter. Periodically mild to intense itching in this area. Not 'on', but directly adjacent to injection site (upper-right arm). No idea if related to vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-05-06
- 2021-06-24
- 2021-09-23
-
2021-10-18
Dose 3 — Pfizer-BioNTech
- 2021-10-29
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2022-01-17
-
2022-04-03
Dose 4 — Moderna
- 2022-04-18
- 2022-04-24
- 2022-05-01
- 2022-05-08
- 2022-05-15
- 2022-07-03
-
2022-09-25
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-02
- 2022-10-07
- 2022-10-09
- 2022-10-16
- 2022-10-23
- 2022-10-30
- 2022-11-06
- 2022-12-25
- 2023-03-26
-
2023-04-23
Dose 6 — Pfizer-BioNTech
- 2023-04-23
- 2023-04-24
- 2023-04-25
- 2023-04-26
- 2023-04-27
- 2023-04-28
- 2023-04-29
- 2023-04-30
- 2023-05-07
- 2023-05-14
- 2023-05-21
- 2023-05-28
- 2023-06-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech | |
| 3 | 2021-10-18 | Pfizer-BioNTech | No |
| 4 | 2022-04-03 | Moderna | No |
| 5 | 2022-09-25 | Pfizer-BioNTech | Flu |
| 6 | 2023-04-23 | Pfizer-BioNTech | No |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): The headache reported above was actually yesterday (3/4/2021) after my first daily v-safe check-in. It was of moderate severity and resolved on its own (no meds) a few hours after onset. No headache today (3/5/2021).
Release 7 — day 28, dose 2
Symptoms: Slightly reddish round patch (not raised), ca. 30mm in diameter. Periodically mild to intense itching in this area. Not 'on', but directly adjacent to injection site (upper-right arm). No idea if related to vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release